Patents by Inventor Norio Shimamoto

Norio Shimamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PACAP receptor protein, method for preparing said protein, and use thereof
    Publication number: 20020155533
    Abstract: This invention discloses a PACAP receptor protein or a salt thereof, a DNA comprising a DNA fragment coding for the protein, a method for preparing the protein, antibody against the protein and use of the protein, DNA and antibodies.
    Type: Application
    Filed: August 22, 2001
    Publication date: October 24, 2002
    Applicant: Takeda Chemical
    Inventors: Haruo Onda, Tetsuya Ohtaki, Yasushi Masuda, Chieko Kitada, Yoshihiro Ishibashi, Masaki Hosoya, Kazuhiro Ogi, Yasunori Miyamoto, Yugo Habata, Norio Shimamoto
  • PACAP receptor protein, method for preparing said protein, and use thereof
    Patent number: 6399316
    Abstract: This invention discloses a PACAP receptor protein or a salt thereof, a DNA comprising a DNA fragment coding for the protein, a method for preparing the protein, antibody against the protein, and use of the protein, DNA, and antibodies. A PACAP receptor protein was purified from the bovine cerebrum. DNAs coding for PACAP receptor proteins were isolated from bovine, rat and human cDNA libraries, and their nucleotide sequences were determined. Further, amino acid sequences deduced from the nucleotide sequences were determined.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: June 4, 2002
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Haruo Onda, Tetsuya Ohtaki, Yasushi Masuda, Chieko Kitada, Yoshihiro Ishibashi, Masaki Hosoya, Kazuhiro Ogi, Yasunori Miyamoto, Yugo Habata, Norio Shimamoto
  • PACAP receptor protein, method for preparing said protein, and use thereof
    Patent number: 5973117
    Abstract: This invention discloses a PACAP receptor protein or a salt thereof, a DNA comprising a DNA fragment coding for the protein, a method for preparing the protein, antibody against the protein and use of the protein, DNA and antibodies.
    Type: Grant
    Filed: May 14, 1997
    Date of Patent: October 26, 1999
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Haruo Onda, Tetsuya Ohtaki, Yasushi Masuda, Chieko Kitada, Yoshihiro Ishibashi, Masaki Hosoya, Kazuhiro Ogi, Yasunori Miyamoto, Yugo Habata, Norio Shimamoto
  • Sulfur-containing fused pyrimidine derivatives, their production and use
    Patent number: 5082838
    Abstract: Disclosed is a compound represented by the formula (I) or a salt thereof: ##STR1## wherein R.sup.1 represents an aliphatic hydrocarbon, aralkyl or aryl group which may be substituted; R.sup.2 represents hydrogen, an aliphatic hydrocarbon group having one or more substituents, an aryl group which may be substituted, an amino group which may be substituted, a formyl group, a nitro group or a halogeno group; A represents a divalent hydrocarbon chain of 2 to 4 carbon atoms which may be substituted; and m represents an integer of 0 to 2, which is useful for treatment and prevention of diseases induced by abnormalities in regulation of reactions in vivo mediated through endothelin or interleukin 1, and of immune diseases and inflammatory diseases.
    Type: Grant
    Filed: June 13, 1990
    Date of Patent: January 21, 1992
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Takehiko Naka, Norio Shimamoto, Taketoshi Saijo, Masahiro Suno
  • Composition for treatment of ischemic disorder in organs
    Patent number: 4948786
    Abstract: The present invention relates to a pharmaceutical composition for the prophylaxis and treatment of ischemic disorder in mammalian organs which contains, as an ingredient, a compound of the formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are independently the methyl group or a hydrogen atom, or a salt thereof.
    Type: Grant
    Filed: January 10, 1989
    Date of Patent: August 14, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Norio Shimamoto, Kazumi Ogata
  • Ester of ascorbic acid 2-phosphate and pharmaceutical use
    Patent number: 4939128
    Abstract: The present invention relates to a compound of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom, carboxylic acid acyl or carbamoyl which may be substituted; R is an aliphatic hydrocarbon group which may be substituted or alicylic hydrocarbon group which may be substituted, or a salt thereof.The compound of the present invention has the effects to prevent and improve dysfunctions caused by oxygen free radicals, and can be used as preventive and therapeutic drugs against dysfunctions in the circulatory system.
    Type: Grant
    Filed: April 5, 1989
    Date of Patent: July 3, 1990
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Kaneyoshi Kato, Norio Shimamoto